These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 35830725)
1. Bovine lactoferrin increases the poly(I:C)-induced antiviral response in vitro. Kobayashi-Sakamoto M; Maeda T; Kimura M; Yusa J; Ito H; Tani H; Kato Y; Hirose K Biochem Cell Biol; 2022 Aug; 100(4):338-348. PubMed ID: 35830725 [TBL] [Abstract][Full Text] [Related]
2. Bovine lactoferrin inhibits SARS-CoV-2 and SARS-CoV-1 by targeting the RdRp complex and alleviates viral infection in the hamster model. He ST; Qin H; Guan L; Liu K; Hong B; Zhang X; Lou F; Li M; Lin W; Chen Y; He C; Liu F; Lu S; Luo S; Zhu S; An X; Song L; Fan H; Tong Y J Med Virol; 2023 Jan; 95(1):e28281. PubMed ID: 36329614 [TBL] [Abstract][Full Text] [Related]
3. The Hu Y; Meng X; Zhang F; Xiang Y; Wang J Emerg Microbes Infect; 2021 Dec; 10(1):317-330. PubMed ID: 33560940 [TBL] [Abstract][Full Text] [Related]
4. Effects of lactoferrin on the production of interferon-λ by the human intestinal epithelial cell line HT-29. Shin K; Oda H; Wakabayashi H; Yamauchi K; Abe F Biochem Cell Biol; 2017 Feb; 95(1):53-56. PubMed ID: 28157388 [TBL] [Abstract][Full Text] [Related]
5. Bovine lactoferrin for the prevention of COVID-19 infection in health care personnel: a double-blinded randomized clinical trial (LF-COVID). Navarro R; Paredes JL; Tucto L; Medina C; Angles-Yanqui E; Nario JC; Ruiz-Cabrejos J; Quintana JL; Turpo-Espinoza K; Mejia-Cordero F; Aphang-Lam M; Florez J; Carrasco-Escobar G; Ochoa TJ Biometals; 2023 Jun; 36(3):463-472. PubMed ID: 36474100 [TBL] [Abstract][Full Text] [Related]
6. Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence. Campione E; Lanna C; Cosio T; Rosa L; Conte MP; Iacovelli F; Romeo A; Falconi M; Del Vecchio C; Franchin E; Lia MS; Minieri M; Chiaramonte C; Ciotti M; Nuccetelli M; Terrinoni A; Iannuzzi I; Coppeta L; Magrini A; Bernardini S; Sabatini S; Rosapepe F; Bartoletti PL; Moricca N; Di Lorenzo A; Andreoni M; Sarmati L; Miani A; Piscitelli P; Squillaci E; Valenti P; Bianchi L Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682731 [TBL] [Abstract][Full Text] [Related]
7. Salaris C; Scarpa M; Elli M; Bertolini A; Guglielmetti S; Pregliasco F; Brun P; Castagliuolo I Gut Microbes; 2021; 13(1):1961970. PubMed ID: 34365895 [TBL] [Abstract][Full Text] [Related]
8. Protective Effects of Lactoferrin against SARS-CoV-2 Infection In Vitro. Salaris C; Scarpa M; Elli M; Bertolini A; Guglielmetti S; Pregliasco F; Blandizzi C; Brun P; Castagliuolo I Nutrients; 2021 Jan; 13(2):. PubMed ID: 33498631 [TBL] [Abstract][Full Text] [Related]
9. Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein. Fernandes MF; Chan JZ; Hung CCJ; Tomczewski MV; Duncan RE Life Sci; 2022 Jul; 301():120624. PubMed ID: 35568225 [TBL] [Abstract][Full Text] [Related]
10. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein. Chien YJ; Chen WJ; Hsu WL; Chiou SS Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of SARS-CoV-2 Infection in Vero Cells by Bovine Lactoferrin under Different Iron-Saturation States. Alves NS; Azevedo AS; Dias BM; Horbach IS; Setatino BP; Denani CB; Schwarcz WD; Lima SMB; Missailidis S; Ano Bom APD; Silva AMV; Barreto Vieira DF; Silva MAN; Barros CA; Carvalho CAM; Gonçalves RB Pharmaceuticals (Basel); 2023 Sep; 16(10):. PubMed ID: 37895823 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway. Chen J; Liu J; Chen Z; Peng H; Zhu C; Feng D; Zhang S; Zhao P; Zhang X; Xu J mSphere; 2022 Aug; 7(4):e0021122. PubMed ID: 35862802 [TBL] [Abstract][Full Text] [Related]
13. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Ikeda M; Nozaki A; Sugiyama K; Tanaka T; Naganuma A; Tanaka K; Sekihara H; Shimotohno K; Saito M; Kato N Virus Res; 2000 Jan; 66(1):51-63. PubMed ID: 10653917 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern. Wotring JW; Fursmidt R; Ward L; Sexton JZ J Dairy Sci; 2022 Apr; 105(4):2791-2802. PubMed ID: 35221061 [TBL] [Abstract][Full Text] [Related]
15. Sequence-Specific Features of Short Double-Strand, Blunt-End RNAs Have RIG-I- and Type 1 Interferon-Dependent or -Independent Anti-Viral Effects. Kannan A; Suomalainen M; Volle R; Bauer M; Amsler M; Trinh HV; Vavassori S; Schmid JP; Vilhena G; Marín-González A; Perez R; Franceschini A; Mering CV; Hemmi S; Greber UF Viruses; 2022 Jun; 14(7):. PubMed ID: 35891387 [TBL] [Abstract][Full Text] [Related]
16. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response. Vishnubalaji R; Shaath H; Alajez NM Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047 [TBL] [Abstract][Full Text] [Related]
17. Discovery and Use of Long dsRNA Mediated RNA Interference to Stimulate Antiviral Protection in Interferon Competent Mammalian Cells. Semple SL; Au SKW; Jacob RA; Mossman KL; DeWitte-Orr SJ Front Immunol; 2022; 13():859749. PubMed ID: 35603190 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules. Zheng Y; Deng J; Han L; Zhuang MW; Xu Y; Zhang J; Nan ML; Xiao Y; Zhan P; Liu X; Gao C; Wang PH Signal Transduct Target Ther; 2022 Jan; 7(1):22. PubMed ID: 35075101 [TBL] [Abstract][Full Text] [Related]
19. Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells (HT-29) by activating various signaling pathways. Jiang R; Lönnerdal B Biochem Cell Biol; 2017 Feb; 95(1):99-109. PubMed ID: 28169560 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells. Verma D; Church TM; Swaminathan S J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]